| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.052 | 0.3 |